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CELLULAR RESPONSE TO EFFICIENT dUTPase RNAi SILENCING
IN STABLE HeLa CELL LINES PERTURBS EXPRESSION LEVELS
OF GENES INVOLVED IN THYMIDYLATE METABOLISM
Ga´bor Mere´nyi,1 Ju´lia Kova´ri,1 Judit To´th,1 Eniko´´ Taka´cs,1 Imre Zagyva,1
Anna Erdei,2 and Bea´ta G. Ve´rtessy1,3
1Institute of Enzymology, Hungarian Academy of Sciences, Budapest, Hungary
2Department of Immunology, Eo¨tvo¨s Lora´nd University, Budapest, Hungary
3Department of Applied Biotechnology, Budapest University of Technology and Economics,
Budapest, Hungary
 dUTPase is involved in preserving DNA integrity in cells. We report an efficient dUTPase
silencing by RNAi-based system in stable human cell line. Repression of dUTPase induced specific
expression level increments for thymidylate kinase and thymidine kinase, and also an increased
sensitization to 5-fluoro-2′-deoxyuridine and 5-fluoro-uracil. The catalytic mechanism of dUTPase
was investigated for 5-fluoro-dUTP. The 5F-substitution on the uracil ring of the substrate did not
change the kinetic mechanism of dUTP hydrolysis by dUTPase. Results indicate that RNAi silencing
of dUTPase induces a complex cellular response wherein sensitivity towards fluoropyrimidines and
gene expression levels of related enzymes are both modulated.
Keywords 5-fluoro-uracil; 5-fluoro-2′-deoxyuridine; dUTPase; thymidylate metabolism;
RNAi
INTRODUCTION
Preservation of genome integrity is crucial for cellular viability and is pro-
vided for by DNA damage repair mechanisms. Fine-tuned regulation of the
levels of the DNA building block nucleotides dTTP and dUTP contributes to
DNA damage repair by preventing incorporation of dUMPmoieties via DNA
polymerases. The enzyme dUTPase, which plays an important role in the de
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370 G. Mere´nyi et al.
FIGURE 1 Pathways of deoxythymidylate biosynthesis and the metabolism of fluoropyrimidines (5FU
and FUdR) in human cells. A) In the de novo deoxythymidylate synthetic pathway, thymidylate syn-
thase (TYMS) processes the rate-limiting step of converting deoxyuridine monophosphate (dUMP) to
deoxythymidine monophosphate (dTMP). In human cells, there are two main sources to provide dUMP
as a substrate for TYMS. In one of the pathways, deoxyuridine triphosphatase (dUTPase) catalyzes the
conversion of deoxyuridine triphosphate (dUTP) into dUMP. In the other pathway, deoxycytidine deam-
inase (DCTD) catalyzes deamination of deoxycytidine monophosphate (dCMP) to dUMP. Alternatively,
in the salvage pathway, thymidine kinase (TK) produces dTMP by phosphorylation of deoxythymidine
(TdR). Subsequent phosphorylation of dTMP by thymidylate kinase (TYMK) results deoxythymidine
diphosphate (dTDP), which is converted to deoxythymidine triphosphate (dTTP) in the further phos-
phorylation step catalyzed by deoxynucleotide diphosphate kinase (dNDPK). dTTP is used for DNA
synthesis in the normal homeostatic cell function. dUTPase activity is essential for DNA integrity, be-
cause it prevents dUTP misincorporation into DNA during replication and repair. B) After cellular
uptake of 5-fluorouracil (5FU), it could be converted into several active metabolites.
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dUTPase Silencing by RNAi in HeLa Cells 371
novo dTTP biosynthesis pathway, is among the major factors responsible for
this regulation: the enzyme-catalyzed reaction sanitizes the dNTP pool by re-
moving dUTP and producing dUMP, the precursor for dTTP biosynthesis.[1]
Lack of dUTPase leads to expansion of the dUTP pool and high levels of
uracil-substitutions in DNA, which overloads the capacity of uracil-directed
base-excision repair.[2–5] In the absence of dUTPase function, repair synthe-
sis will reincorporate uracil and the repair pathway is therefore transformed
into a hyperactive futile cycle, resulting in multiple DNA breaks and cell
death. This process was termed thymine-less cell death.[6,7] The pathway of
thymidylate biosynthesis consists of both de novo and salvage constituents.
Besides dUTPase, deoxycytidine deaminase (DCTD) is considered to sup-
ply precursors for the de novo biosynthesis. In the case of salvage pathway
thymidine kinase (TK) plays an important role in formation thymidine to
dTMP, which is converted to dTDP in a subsequent phosphorylation step
catalyzed by thymidylate kinase (TYMK). TYMK is an essential enzyme which
has an integration function onboth constituents of the dTTPbiosynthesis. Fi-
nally, the dTDPwill be the substrate for deoxynucleotide diphosphate kinase
(dNDPK), providing dTTP nucleotides for DNA synthesis[1] (Figure 1A).
Thymine-less cell death is also a widely used strategy in anticancer
chemotherapy applying fluoropyrimidines.[8] 5-Fluorouracil (5FU) and 5-
fluoro-2′-deoxyuridine (FUdR) elicit cell killing by a complex mechanism
of action (cf. Figure 1B). One of the active metabolites formed from 5FU
within the cells is 5-fluoro-2′-deoxyuridinemonophosphate (FdUMP), which
binds to and inhibits thymidylate synthase (TYMS).[8] TYMS processes the
rate-limiting step of converting dUMP to dTMP. Further active metabolites
are the 5-fluoro-uridine triphosphate (FUTP) and 5-fluoro-2′-deoxyuridine
triphosphate (FdUTP), which may be incorporated into RNA and DNA,
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
FIGURE 1 (Continued) During the first step of the main anabolic pathway, 5FU is converted by orotate
phosphoribosyl transferase (OPRT) into fluorouridine monophosphate (FUMP). Alternatively, FUMP
can also be produced through the 5-fluoro-uridine (FUR) intermediate by the sequential actions of uri-
dine phosphorylase (UP) and uridine kinase (UK). Then FUMP is phosphorylated by uridinemonophos-
phate kinase (UMK), resulting in fluorouridine diphosphate (FUDP), which is either reduced by ribonu-
cleotide reductase (RR) to fluorodeoxyuridine diphosphate (FdUDP) and subsequently converted to
fluorodeoxyuridine triphosphate (FdUTP) by uridine diphosphate kinase (UDK), or further phospho-
rylated by UDK to fluorouridine triphosphate (FUTP). FUTP and FdUTP represent two major active
metabolites of 5FU. FUTP could be misincorporated into RNA by RNA polymerase (RNA Pol) result-
ing RNA damage by perturbation and disruption the normal RNA processing. FdUTP could be either
hydrolyzed to pyrophosphate and fluorodeoxyuridine monophosphate (FdUMP) by dUTPase or mis-
incorporated into DNA by DNA polymerase (DNA Pol) during the replication process, causing DNA
damage. During the second relevant anabolic pathway, 5FU is converted by thymidine phosphorylase
(TP) to fluorodeoxyuridine (FUdR) and subsequently phosphorylated by TK, producing the other ac-
tive metabolite, FdUMP, which is a potent inhibitor of TYMS. FdUMP can be produced from FdUDP
in the reversible reaction of UMK as well. FdUMP can bind to the nucleotide-binding site of TYMS,
resulting a ternary complex with the enzyme and its co-factor methylene tetrahydrofolate (CH2-THF)
(not shown).[30] Blocking of TYMS activity by FdUMP is a rate limiting step of the dTTP synthesis.
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372 G. Mere´nyi et al.
respectively.[9–13] FUTP misincorporation into RNA is considered to induce
major disruption of RNA processing pathways including pre-rRNA and pre-
mRNAmaturing, posttranscriptional modification of tRNA and proper func-
tioning of snRNA/protein complexes affecting gene splicing. Furthermore,
previous studies revealed the fact that polyadenylation of mRNA is strongly
inhibited at a low concentration of 5FU.[12,14,15] For a detailed understanding
of the mechanism of action of fluoropyrimidines, several studies focused on
different enzymes in the thymidylate synthesis pathway.[8,13] Interestingly,
resistance against 5FU was shown to be developed as a result of dUTPase
overexpression in different cancer cell lines.[16,17]
With respect to the relative importance of enzymes taking part in the
dTTP biosynthesis pathway, some approaches were performed to repress
the dUTPase gene (DUT), TYMK and TYMS genes in different types of
human cell lines. Transient silencing of dUTPase by RNAi and its effect
on sensitizing cells against FUdR, but not 5FU, usually administered in the
clinics, was addressed.[5] These experiments resulted in significant transient
silencing levels, with varied efficiency in different cell lines.[5,18,19] Efficient
RNAi experiments were also reported to silence the TYMK and TYMS genes
in colon cancer cell lines.[20]
In the present study, we aimed at generation of stable HeLa cell lines
in which either the DUT or the TYMK gene is constantly silenced by a
vector-based RNAi system. With respect to the essential functions of the
aforementioned enzymes in thymidylate metabolism, we aimed to charac-
terize the gene expression pattern of DUT, TK, TYMK, DCTD, and TYMS
enzymes as molecular responses to the gene silencing (cf. Figure 1A). Cell
viability experiments of the generated stable cell lines with respect to the ef-
fect of fluoropyrimidines (5FU, FUdR) were also performed. Additionally, in
enzyme kinetics and ligand binding experiments, we addressed the catalytic
mechanism of human dUTPase in the reaction of 5-fluoro-2′-deoxyuridine
triphosphate (FdUTP) cleavage.
RESULTS AND DISCUSSION
Effective Silencing of the DUT Gene by Vector-Based RNAi
Our main goal was to examine the cellular and molecular events caused
by DUT gene silencing in human TR-HeLa cell line using a vector-based
RNAi system.
To achieve an increased RNAi efficiency, we used four shRNA oligos
(Table 1) with distinct recognition sites on the common coding regions of
the mRNAs of both dUTPase isoforms (Scheme 1). As a negative control, we
used a scrambled-shRNA (sc-shRNA) construct (Table 1). Stable transfected
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dUTPase Silencing by RNAi in HeLa Cells 373
SCHEME 1 Recognition sites for shRNA oligos directed to mRNA of both dUTPase isoforms. Schematic
representation shows the coding sequences of dUTPase isoforms (DUT-N, nuclear isoform, DUT-M, mi-
tochondrial isoform, respectively) and the target positions of shRNA oligos directed to distinct sequences
(indicated with arrows) placed in the common coding region of DUTmRNAs. The five conserved motifs
are boxed in gray. The sequence of the shRNA oligos are given in Table 1.
cell lines were generated according to methods described (Scheme 2) to
create a highly efficient silencing system.
Immunoblot results (Figure 2A) revealed that no protein could be ob-
served in the case of the dut-shRNA4X cell line compared to control cell
lines (mock and untransfected control), indicating an efficient silencing
effect of the shRNA constructs. Quantitation of mRNA levels of cell lines
correlated positively to protein levels detected by immunoblot (Figure 2B,
SCHEME 2 Generation of stable cell lines used in the present study. TR-HeLa cells were transfected
with the respective vector-constructs (indicated in boxes with white background) and further selected by
using the appropriate antibiotics to generate stable cell lines (indicated in boxes with gray background).
Experiments were conducted as described in the Materials and Methods section.
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374 G. Mere´nyi et al.
TABLE 1 Summary of the shRNA vector constructs used in RNAi experiments
Target sites
Name of shRNA vector
constructs Location in coding sequence Sequence (sense)
pSup.p-200 200–219 taccacctatggagaaagc
pSup.p-230 230–249 cggacattcagatagcgct
pSup.p-350 350–369 aatgttggtgttgtactgt
pSup.p-413 413–432 ttgcacagctcatttgcga
pEntr-509 509–527 agacacgactttgaactgg
pEntr-sc — Gaacctggtgcaacgtata
Name of the shRNA vector constructs, localization sites, and sense sequences are indicated.
cf. also Table 2). dUTPase mRNA level was significantly reduced (17-fold at
P < 0.004) in the dut-shRNS4X cell line compared to the control cell line
(sc-shRNA).
In our system, we could achieve robust RNAi silencing on the DUT gene
with practically undetectable protein levels.
Effect of the DUT Gene Repression by RNAi on Expression Levels
of Other Genes Involved in Thymidylate Metabolism
We wished to assess the putative effects of dUTPase silencing on expres-
sion the levels of other enzymes closely involved in thymidylate metabolism.
Based on this pathway, we selected four additional enzymes (cf. shaded boxes
on Figure 1A) that catalyze reactions sequential to dUTPase.
Respective mRNA levels were determined by quantitative PCR measure-
ments in control (mock, sc-shRNA and untransfected control) and in dut-
shRNA4X cell lines (Figure 2C). Effective silencing of the DUT gene led to
a significant (P < 0.02) 3.2-fold increment of the TYMK gene expression.
In addition, a significant (P < 0.04) 2-fold elevation was also observed for
the mRNA level of the TK gene as well. Interestingly, reduction of DUT
expression caused a 2-fold decrease in DCTD expression, but no noticeable
up-regulation could be observed for gene expression of the TYMS enzyme.
These data suggest that in our experiments, silencing of the DUT gene
induces TYMK and TK gene expression increments in TR-HeLa cells. In the
salvage pathway, thymidine serves as an input for dTMP synthesis via the
reaction catalyzed by TK. Elevated levels of TK and TYMK gene expressions
could provide a sufficient amount of dTMP and dTDP nucleotides for dTTP
synthesis in cells in which the dUTPase protein is particularly undetectable.
Reduction of DCTD gene expression was unexpected as the function of
DCTD is similar to dUTPase as both enzymes produce the TYMS precursor
dUMP. Lack ofmodulation of TYMS expression by dUTPase silencing should
also be considered within the context of other potential levels of regulation
for this enzyme, as it is known that the TYMS protein efficiently regulates
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dUTPase Silencing by RNAi in HeLa Cells 375
FIGURE 2 Downregulation of the DUT gene by RNAi and its effect on expression patterns of genes
involved in thymidylate biosynthesis in TR-HeLa cell. A) Immunoblot assay shows the efficiency of RNAi
on dUTPase protein level in dut-shRNA4X cell line compared to control cell lines (untransfected control
and mock). The blots were reacted with polyclonal anti-serum to human dUTPase and with monoclonal
antibody to α-tubulin, followed by reaction with a horseradish peroxidase conjugated secondary anti-
bodies. B) Downregulation of the DUT gene detected by quantitative-PCR analysis. DUT mRNA levels
were quantified in stable cell lines (mock, sc-shRNA, and dut-shRNA4X) by using specific primer pair
for amplification. C) Quantitative-PCR analysis shows the effect of the DUT gene silencing on expres-
sion patterns of genes involved in thymidylate biosynthesis in dut-shRNA4X stable cell line compared to
control cell lines (mock, sc-shRNA). TK, DCTD, TYMK, and TYMS genes mRNA levels were measured by
using gene specific primer pairs for amplification. For immunoblot and quantitative-PCR experiments
cells were treated with tetracycline at the concentration of 1 µg/ml for 72 hours, then harvested and
prepared for appropriate analysis. ∗P < 0.004; ∗∗P < 0.02; ∗∗∗P < 0.05. P values were calculated using a
two-tailed student’s t test. Data are presented as the mean ±SD. of two independent relative expression
ratio determinations. Experiments were conducted as described in the Materials and Methods section.
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376 G. Mere´nyi et al.
TABLE 2 Summary of gene specific primer sequences designed for quantitative-PCR analysis
Quantitative PCR primer pairs
Sequences (5′-3′)
Gene Forward Reverse
GAPDH gcggggctctccagaacatcatc gacgcctgcttcaccaccttcttg
DUT tggaagagtggctccacggt ccgttcgcaaatgagctgtgc
TK tccgtcgcttccagattgctcag ctgcccctcgtcgatgcctatg
DCTD tcgaccgatgtgaaaggctgtag caggagcctcgcagcagttg
TYMK tccaccagctcatgaaagacacg tgggcagccttgggtcacttc
TYMS ggcagatccaacacatcctccg Caaaacacccttccagaacacacg
Primer pairs were designed by DNA STAR/Primer Select software.
its own mRNA.[21] Our present results suggest that TYMK and TK may play
important roles in the reconstitution of the thymidylate biosynthesis pathway
in TR-HeLa cells, in which the DUT gene is effectively repressed by RNAi.
Downregulation of dUTPase by RNAi Sensitizes Cells
to Fluoropyrimidines
According to previous studies, elevated dUTPase levels protect cells
against agents perturbing thymidylate de novo biosynthesis, such as fluo-
ropyrimidines (5FU and FUdR) (16,22,23). Moderate dUTPase silencing by
RNAi increased sensitivity of several cancer cell lines to FUdR,[5] but the ef-
fect was not studied in the context of 5FU agent. Comparison of the effects of
5FU and FUdR is a relevantmeans to assess drug-caused perturbation at RNA
as compared to DNA levels, since 5FU can also result in uracil-substituted
RNA, whereas FUdR is dedicated for perturbations at the DNA level (cf.
Figure 1B).[24]
To determine whether the observed drastic repression of the DUT gene
by RNAi had any effect on cellular response to 5FU and FUdR, dut-shRNA4X
and control (sc-shRNA and untransfected control) cell lines were exposed
to 5FU and FUdR in different manners. The concentration-dependent re-
sponses of cells indicated that repression of the DUT gene increases the
sensitivity of dut-shRNA4X cells for both 5FU and FUdR, with a much more
increased sensitization for FUdR (Figures 3A and 3B). There were large
differences in IC50 concentration values of repressed cell line compared to
values of control cell lines: the dut-shRNA4X cell line was ∼6-fold more
sensitive to 5FU and ∼40-fold more sensitive to FUdR, relative to untrans-
fected control (Table 3). Cell viability was examined in a time-dependent
manner as well. The drug tolerances of cell lines were evaluated at fixed con-
centrations of 5FU and FUdR compounds. Results indicated an increased
sensitivity of dut-shRNA4X cells for both 5FU and FUdR agents compared to
control cells. Growth inhibition of repressed cell line was more pronounced
in the case of the FUdR agent (Figures 3C and 3D).
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dUTPase Silencing by RNAi in HeLa Cells 377
FIGURE 3 Downregulation of the DUT gene induces elevated sensitization effects to 5FU and FUdR in
TR-HeLa cell. A/B) Growth inhibition effects of 5FU (A) and FUdR (B) were evaluated in concentration-
dependent manner on control (– – –), sc-shRNA ( . . . ), and dut-shRNA4X (—) cell lines. Cells were
treated for 72 hours with various concentrations of 5FU or FUdR. (C ,D), Growth inhibition effects of
5FU (C) and FUdR (D) were carried out in time-dependent manner on control, sc-shRNA and dut-
shRNA4X cell lines as well. Cells were treated with discrete concentrations of 5FU (30 µM) or FUdR (30
µM) for different time intervals (0, 24, 48, 72 hours). Inhibition assay results are reported as percentage
of untreated control for each cell lines. Measurements were conducted at the present of tetracycline at
the concentration of 1 µg/ml. Data represent the mean ±SD of three independent determinations at
each concentration. Experiments were performed as described in the Materials and Methods section.
In summary, stable silencing of the DUT gene induces specific responses
within the thymidylate metabolism pathway: a dramatic enhancement of the
FUdR cell sensitizing effect is observed. DUT silencing also increases cellular
sensitivity towards 5FU, the drug widely administrated in clinical chemother-
apy, although in a less drastic manner. To compare the initial phase (the low
concentration range) of the dose dependency curves of different drugs, it
does seem that only 5FU induces an elevated toxic effect on all cell lines in an
exponential manner. The latter observation suggests that after 5FU uptake
into the cells, the drug is more likely to be anabolized through the uridylate
metabolism rather than via the deoxythymidylate synthetic pathway. In the
uridylate metabolic pathway, 5FU is used to generate precursors for FU-RNA
synthesis. Thus, 5FU may have much more drastic damaging effects on RNA
levels than it directly influences the TYMS catalyzed rate-limiting step of
deoxythymidylate metabolism pathway.
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378 G. Mere´nyi et al.
TABLE 3 Relationship between tolerance to fluoropyrimidines and relative gene expressions detected
in stable shRNA cell lines
Drug treatment
Relative expression of genes
shRNA FUdR 5FU
cell lines IC50 (µM) IC50 (µM) DUT TYMK TK
Control 200.5± 3.5 21.1± 5.2 1 1 1
sc-shRNA 254.4± 1.2 21.5± 10.3 1.04± 0.08 1.0± 0.1 1.1± 0.01
dut-shRNA4X 5.0± 3.5 3.6± 1.3 0.06± 0.01 3.2± 0.3 1.9± 0.18
tymk-shRNA 170.1± 2.1 14.8± 3.5 0.80± 0.03 0.23± 0.02 1.2± 0.07
First two columns represent the IC50 values for 5FU and FUdR of the different stable shRNA cell
lines. Further columns list relative expression levels of DUT, TYMK, and TK genes, as determined by
quantitative-PCR. Results clearly show that DUT silencing by RNAi induces much elevated sensitivity
against 5FU and FUdR, while TYMK silencing on its own induces much less sensitization against the same
compounds. Experiments were conducted as described in the Materials and Methods section.
Silencing of the TYMK Gene and Its Effect on Expressions
of Genes Involved in Thymidylate Metabolism
Since cellular response to DUT silencing resulted in an upregulation
of TYMK expression, we aimed to examine the gene expression patterns
of genes involved in thymidylate metabolism while exerting repression of
this enzyme by RNAi. To achieve our target, we generated the tymk-shRNA
stable cell line in which the TYMK gene was permanently repressed (Table 1
and Scheme 2). Interestingly, in an early experiment, deletion of the TYMK
homologue cdc8 gene in yeast was found to be lethal.[25]However, in another
study, repression of the TYMK gene by RNAi did not induce direct lethal
consequences in human colon cancer cell lines.[20]
Quantitative PCR results revealed that silencing of the TYMK gene by
RNAi achieved a significant (P < 0.02) 4-fold reduction of TYMK expression
in the tymk-shRNA cell lines compared to the value of control cell lines
(Figure 4A). To determine whether this reduction had any effect on expres-
sion levels of DUT, TK, DCTD, and TYMS genes, quantitative PCR measure-
ments were performed to measure their mRNA levels in tymk-shRNA cells.
No significant (P > 0.05) changes could be observed in case of the genes
examined in the TYMK repressed cell line (Figure 4B). These data indicate
that the 4-fold reduction in TYMK expression does not perturb the gene
expression patterns of genes involved in thymidylate metabolism.
Effect of TYMK Silencing on Response to Fluoropyrimidines
To examine whether TYMK silencing could cause any enhanced sensitiv-
ity to fluoropyrimidines, tymk-shRNA and control cell lines (sc-shRNA and
untransfected control) were exposed to 5FU and FUdR drugs in different ex-
perimental manners. According to the results of concentration-dependent
responses, the IC50 values of the tymk-shRNS cell line showed a very slight
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dUTPase Silencing by RNAi in HeLa Cells 379
FIGURE 4 Downregulation of the TYMK gene by RNAi and its effect on expression patterns of genes
involved in thymidylate biosynthesis in TR-HeLa cell. A) Downregulation of the TYMK gene detected by
quantitative-PCR analysis. TYMK mRNA levels were quantified in tymk-shRNA cell line compared to con-
trol cell lines (mock, sc-shRNA) by using gene specific primer pair for amplification. B) Quantitative-PCR
measurements show the effect of the TYMK gene silencing on expression patterns of genes involved in
thymidylate biosynthesis in tymk-shRNA compared to control cell lines. DUT, TK, DCTD and TYMS genes
mRNA levels were quantified by using gene specific primer pairs for amplification. For the quantitative-
PCR experiments the cells were treated with tetracycline at the concentration of 1 µg/ml for 72 hours
then harvested and prepared for analysis. ∗P < 0.02. P value was calculated using a two tailed Student’s t
test. Data are presented as the mean ±SD. of two independent relative expression ratio determinations.
Experiments were conducted as described in the Materials and Methods section.
sensitization to fluoropyrimidines compared to values of control cell lines
(Figures 5A and 5B and Table 3). Furthermore, the viability of the repressed
cell line was assessed in a time-dependent manner, at fixed concentrations
of 5FU and FUdR drugs. Results showed a moderate but not significant in-
crease in the sensitivity of tymk-shRNA cells for FUdR agents compared to
control cells, while no noticeable sensitivity to 5FU could be detected in the
case of the repressed cell line (Figures 5C and 5D). Data indicate that the
4-fold reduction of the TYMK gene expression does not robustly perturb the
normal physiological function and does not induce any robust sensitization
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FIGURE 5 5FU and FUdR treatments of TR-HeLa cells with downregulation of the TYMK gene. A/B)
Growth inhibition effects of 5FU (A) and FUdR (B)were estimated in a concentration-dependentmanner
on control (– – –), sc-shRNA ( . . . ), and tymk-shRNA (—) cell lines. Cells were administrated for 72 hours
with various concentrations of 5FU (0–250 µM) or FUdR (0-500 µM). C/D) Growth inhibition effects
of 5FU (C) and FUdR (D) were performed in time-dependent manner on control, sc-shRNA and tymk-
shRNA cell lines as well. Cells were treated with discrete concentrations of 5FU (30 µM) or FUdR (30
µM) for different time intervals (0, 24, 48, 72 hours). Inhibition assay results are reported as percentage
of untreated control for each cell lines. Measurements were conducted at the present of tetracycline at
the concentration of 1 µg/ml. Data represent the mean ±SD of three independent determinations at
each concentration. Experiments were performed as described in the Materials and Methods section.
of the cells to fluoropyrimidines. The observation suggests that in spite of
significant TYMK silencing, the residual part of the enzyme could provide
sufficient enzymatic activity for maintaining proper dTTP synthesis. In this
respect, it is also to be noted that since the treatment with fluoropyrimidines
results in inhibition of the TYMS enzyme, the substrate pool for TYMK will
also be reduced in these cells.
dUTPase Activity Measurement by Colorimetric Assay
With respect to quantitative PCR and immunoblot results that indicated
highly efficient silencing of the DUT gene in the dut-shRNA4X cell line,
we also attempted to measure the dUTPase enzyme activity in whole cell
extracts using a direct colorimetric assay. Results revealed that the actual
dUTPase activity was relatively low in the dut-shRNA4X cells ((0.17± 0.04)×
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dUTPase Silencing by RNAi in HeLa Cells 381
10−3 unit/mg cell extract) (6.68%) as compared to the control cells ((2.63
± 0.1) × 10−3 unit/mg cell extract) (100%). Data are in agreement with the
mRNA and protein values of cell lines described above.
5F-Substitution Results in Subtle Changes in the Kinetic
Mechanism of dUTP Hydrolysis by dUTPase
In the earlier work of Caradonna and Cheng,[26] the observation that
human dUTPase can hydrolyze FdUTP was reported (cf. also Quesada-
Soriano[27] for a recent report). We wished to characterize this catalytic
property of human dUTPase in quantitative detail to provide further mecha-
nistic insights. Adopting themethoddescribed inToth et al.,[28] wemeasured
relevant thermodynamic and kinetic parameters of FdUTP binding and hy-
drolysis (Figure 6 and Table 4). The stopped-flow traces recorded for the
FdUTP hydrolysis reactions (Figure 6A) showed equivalent characteristics
to that of unsubstituted dUTP hydrolysis, indicating that similar confor-
mational changes occur during the enzymatic cycle (cf. Toth et al.[28]). The
timescales of these conformational changes, however, differ between FdUTP
and dUTP. FdUTP binding to and dissociation from the enzyme are 2-fold
slower than that of dUTP, based on the first binding phase of the stopped-
flow curves (Figure 6B). The conformational transition of the collision com-
plex into the catalytically competent conformation, however, is twice as fast
as in dUTP (kISO, obs = 40 ± 24 s−1). We calculated this parameter from
the second, concentration independent, exponential phase of the reaction
curves shown in Figure 6A. Our single turnover experiments in Figure 6C
(one substrate/enzyme can be converted) indicated that hydrolysis remains
rate-limiting and occurs with similar rates to that of physiological dUTP.
We also measured steady-state rates using the pH-indicator method[29]
and observed similar enzymatic activities with dUTP and FdUTP (data not
shown).
It is known that FdUMP acts as a potent inhibitor of thymidylate syn-
thase.[30] Since dUMP is a product and a competitive inhibitor of dUTPase,
we were curious to know whether the 5F-derivative displays an increased
dUTPase affinity and more potent inhibition. To this end we measured the
equilibrium binding of FdUMP to dUTPase (Figure 6D) and compared it
to both the enzyme−dUMP and enzyme−FdUTP dissociation constants. We
found that the 5F-substitution resulted in a slightly weaker dUMP binding,
whereas the binding of FdUTP seems to be unaffected. We assessed the Kd
for the enzyme−FdUTP complex by amplitude titration of the FdUTP bind-
ing transient kinetic experiments (Figure 6D inset). Moreover, calculation
of the Kd from the kinetic parameters also results in a similar value (Kd =
koff/kon = 0.67 µM).
As a summary of our kinetic investigations, we report that the 5F-
substitution on the uracil ring of the substrate does not change the kinetic
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FIGURE 6 Kinetic characterization of the 5FdUTP hydrolysis cycle. A) Fluorescence time courses on
the reaction of 0.5 µM hDUTF158W upon mixing with buffer or with 1–10 µM 5FdUTP. The binding
phases of the stopped-flow traces are shown in light gray, black lines are double exponential fits to the
curves. Each curve represents the average of 5 traces and the entire series was repeated twice (Inset:
complete time courses shown in linear time scale). B) 5FdUTP binding to hDUTF158W. Rate constants
(kobs) extracted from the exponential fit to the initial phase of the reactions shown in panel A were
plotted against 5F-dUTP concentrations. A linear fit to the data resulted in the following association and
dissociation rate constants: kon = 59 ± 3 µM−1s−1, koff = 27 ± 15 s−1. C) Single turnover hydrolysis
curve upon mixing 22.5 µM hDUTF158W with 13 µM 5FdUTP. A triple exponential function (black line)
is fitted to the data points (gray circles). The third phase characterized with an increasing fluorescence
corresponds to the single turnover hydrolysis rate constant kSTO (=kcat) = 4.2 ± 0.01 s−1. The inset
shows the same curve in linear timescale. D) 5FdUTP and 5FdUMP equilibrium binding to hDUTF158W.
Fractional binding data for 5FdUTP was calculated from the amplitudes of the exponential fits to the
binding phases (panel A). 5FdUMP binding was measured separately in an equilibrium fluorescence
titration setup using 2.7 µM hDUTF158W and increasing amounts of ligand. Quadratic fits to the titration
curves yielded Kd (5FdUTP) = 0.3 ± 0.04 µM and Kd (5FdUMP) = 46 ± 4 µM. The inset displays the
5FdUTP binding curve again in a smaller concentration scale.
mechanism of dUTP hydrolysis by dUTPase. It alters the rate constants of
the binding steps but not the overall affinity for the substrate. Product inhi-
bition by FdUMP may be slightly weaker than that of dUMP. This important
feature supports the suggestion that dUTPase interferes with the action
of 5FU-based drugs in a dual manner at the FdUTP level: on one hand, it
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TABLE 4 Comparison of kinetic parameters for FdUTP and dUTP hydrolysis
as catalyzed by human dUTPase
FdUTP substrate dUTP substrate[28]
kcat (s−1) 4.2± 0.01 6.8± 2
kon (µM−1s−1) 59± 3 121
koff (s−1) 27± 15 100
kISO, obs (s−1) 40± 24 24± 6
kcat is the catalytic rate constant, kon and koff are the rate constants for
binding and dissociation of substrate to dUTPase, kISO is the rate constant for
the conformational transition of the collision complex into the catalytically
competent conformation. Data for dUTP are taken from the literature.[28]
produces the physiologically relevant thymidylate synthase inhibitor FdUMP,
while on the other hand, it eliminates FdUTP, thereby preserving DNA from
its incorporation.
CONCLUSION
dUTPase and TYMK are crucial for normal homeostatic function of the
cell through dTTP synthesis, but both of these enzymes are also involved in
metabolism of fluoropyrimidines (cf. Figure 6 and Lavie and Conrad[31] for
TYMK).We have shown that the catalytic action of dUTPase on FdUTP is very
similar to its action on the physiological substrate dUTP in most quantitative
details (cf. Figure 6). The sanitizing action of dUTPase, that is, its crucial
role in eliminating the nonphysiological nucleotide building block dUTP,
is therefore similarly manifested for FdUTP also. Thus, depriving cells from
the dUTPase-dependent preventive repair mechanism presumably leads to
increases in both dUMP and FdUMP substitutions in the DNA. Repressing
the dUTPase function has a much more pronounced sensitization effect
toward FUdR, acting at the DNA level, as compared to 5FU, acting at both
the RNA and DNA levels, indicating the dedicated role of dUTPase in DNA
protection. dUTPase-silencing induced sensitization is, however, strong even
against 5FU. This is important especially from the point of view of the clin-
ically administered drug regimes. In addition to the sensitization effects,
dUTPase silencing also induces significantly increased expression levels of
TYMK and TK genes, which are both involved in the salvage pathway, but
interestingly, not that of the TYMS gene. This result suggests that in addition
to the relation previously proposed between dUTPase and TYMS in defin-
ing the mechanism of action of fluoropyrimidines.[15] the communication
network needs to be broadened to include TK and TYMK as well. Our re-
sults present convincing evidence to the notion that actual cellular response
to fluoropyrimidines will be determined by multiple factors in thymidylate
metabolism.
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MATERIALS AND METHODS
Materials
General chemicals were obtained from Sigma-Aldrich (Darmstadt,
Germany). FdUTP and FdUMP were purchased from Jena Bioscience
GmbH (Jena, Germany), antibiotics from Invitrogen (Carlsbad, CA, USA),
and oligonucleotides from Sigma and Eurofins MWG Synthesis GmbH
(Ebersberg, Germany).
Cell Culture
Human cervical adenocarcinoma, T-REx-HeLa (TR-HeLa) cell line
(Invitrogen) was maintained and cultured according to the manufacturer’s
instructions. This cell line constitutively and stably expresses the Tet re-
pressor (TetR) from the pcDNA6/TR TetR expression plasmid to facilitate
rapid regulation of the vector-based inducible RNA interference system in a
tetracycline-dependent manner. In our experimental conditions, exponen-
tially growing cells were treated with tetracycline at the concentration of 1
µg/ml for 72 hours in order to induce the shRNA expression.
Establishment of RNAi Vector Constructs
In our RNAi experiments two different types of tetracycline inducible
RNAi systems were applied: i) pSuperior vector (pSup.p) (Oligoengine,
Seattle, WA, USA) for DUT gene silencing and ii) H1 RNAi Entry Vec-
tor (pEntr) (Invitrogen) for TYMK gene silencing. Four target sites for the
DUT gene (nucleotides 200–219; 230–249; 350–369, 413–432; respectively)
and one target site for the TYMK gene (nucleotides 509 to 527) were chosen
within open reading frames of the genes (Table 1 and Scheme 1). Selection
of target sites was partially based on previous studies.[5,17,19] Scrambled se-
quence was derived from the sequences of target sites of DUT and TYMK
genes. We generated four DNA constructs directed against the DUT gene,
pSup.p-200, −230, −350, −413, one against the TYMK gene, pEntr-509,
and one for scrambled control, pEntr-sc (Table 1). Vector constructs were
established according to the manufacturer’s instructions.
Transfection Procedures for Generation of Stable Cell Lines
To generate stably transfected cell lines, we used Lipofectamin 2000
reagent (Invitrogen). The transfection procedures were carried out accord-
ing to the manufacturer’s instructions. For DUT gene silencing, pSup.p-200,
-230, -350, and -413 DNA constructs were mixed in a 1:1:1:1 ratio before use.
For TYMK silencing, the pEntr-509 vector; for mock generation, the pSup.p
vector; and for generation of scrambled control, the pEntr-sc vector was
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dUTPase Silencing by RNAi in HeLa Cells 385
used on its own, respectively. Finally, four stable cell lines (dut-shRNA4X,
tymk-shRNA, mock and sc-shRNA) were selected by respective antibiotics
(Scheme 2).
RNA Isolation and Reverse Transcription
RNA was isolated using RNeasy Plus Mini Kit (Qiagen GmbH, Hilden,
Germany). RNA samples were quantified and analyzed by ND-1000 UV-
vis spectrophotometer (Thermo Scientific, West Palm Beach, FL, USA).
An amount of 1 µg DNA free total RNA from each sample was reverse-
transcribed using M-MuLV reverse transcriptase according the manufac-
turer’s protocol (Fermentas, Ontario, Canada).
Quantitative PCR
Primer pairs for quantitative PCR (Q-PCR) were designed by DNA
STAR/Primer Select software (Table 2). Real-time PCR reactions were per-
formed in aMx3005PQPCR System (Stratagene, Agilent Technologies, Inc.,
La Jolla, CA, USA) using Eva Green dye (Bioline, Csertex Kft., Budapest,
Hungary) and ImmoMix (Bioline). The reaction conditions were optimized
by determining the amplification efficiency for each primer pair and ampli-
con. To determine the amplification efficiency, serial dilutions of the cDNA
template from control cells were used to produce a standard curve for each
amplicon. Slopes were calculated by linear curve fitting. Efficiencies (E) were
determined by applying the following equation E= 10[−1/slope]. To standard-
ize all the samples, GAPDH was used as an endogenous reference gene. We
used a control (untransfected) cell line as a calibrator in our experiments.
The target quantities were normalized toGAPDHand calibrated using values
of controls defined as 1.0. Relative expression ratios of the examined genes
were calculated using the comparative Ct method (2−Ct) with correction
of PCR efficiency according to Pfaffl method.[32] Relative expression ratios
of examined genes mean an n-fold difference relative to the calibrator. The
quantitative analysis for each candidate gene was performed with two biolog-
ical samples using independent cell cultures at different times. Each Q-PCR
reaction for each gene was performed in technical triplicates (performed in
three independent wells). After conducting the Q-PCR reactions, the means
were calculated from the values measured for samples from independent
wells. Standard deviations (SDs) were calculated from the means of Q-PCR
measurements at different times using independent cell cultures. Signifi-
cant alterations were calculated using the means of interest gene expression
relative to means of gene expression detected in the scrambled-shRNA (sc-
shRNA) cell line. A two-tailed student’s t test was used for estimations of
significance, with P < 0.05 considered to be significant.
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386 G. Mere´nyi et al.
Data were collected and quantitatively analyzed by the MxPro QPCR and
OriginPro 7.5 softwares. Significant alterations were calculated for values of
interest relative to values detected in the scrambled-shRNA cell line.
Generation of dUTPase Anti-Serum
Experiencing nonspecific characters of commercially available antibod-
ies against human dUTPase, we generated a new anti-serum following the
procedure described in Barabas et al.[33] Briefly, rabbits were immunized
with recombinant human dUTPase.[34] Three immunising shots were given
at time intervals of 2–3 weeks, first in complete then in incomplete Freund’s
adjuvant or in physiological saline.
Immunoblot Analysis of Proteins
Immunoblot analysis was done according to the method described pre-
viously.[35] First, the membranes were reacted with rabbit serum contain-
ing polyclonal anti-dUTPase antibodies (used at 1:5.000 dilution), mouse
anti α-tubulinmonoclonal antibody (Sigma-Aldrich), respectively. Secondly,
the membranes were incubated with horseradish peroxidase conjugated
secondary antibody: anti-rabbit IgG (Amersham Pharmacia Biotech AB,
Uppsala, Sweden) and anti-mouse IgG (Sigma), respectively.
Growth Inhibition Assay
Cell viability was evaluated by an AlamarBlue Cell Viability Assay Kit
(Biotium, Inc., Hayward, CA, USA) according to the manufacturer’s instruc-
tions. Exponentially growing cells in an equal number (2000 cells/well)
were exposed for 72 hours to increasing concentrations of 5FU (0-250 µM)
or FUdR (0-500 µM) in the presence of 1 µg/ml tetracycline. Alternatively,
to examine the time-dependent character of drug treatments, growth inhibi-
tion assays were also carried out by applying discrete concentrations of 5FU
(30µM) and FUdR (30µM) for different time intervals (0, 24, 48, 72 hours).
The resulting fluorescence was measured using the micro-titer plate-reader
WallacVictor-2 (Perkin Elmer, Waltham, Massachusetts, USA). IC50 values
were defined as the applied drug (5FU, FUdR) concentration (µM) required
for a half-maximal inhibitory effect on cell growth. IC50 values were calcu-
lated by nonlinear curve fitting using Origin Lab 7.5 software. Experiments
were performed in triplicate and standard deviation values were calculated.
dUTPase Activity Measurement by Colorimetric Assay
in Cellular Extracts
In order to examine the dUTPase activity of the dut-shRNA4X cells, we
adopted the malachite green colorimetric assay as described previously.[36]
Control anddut-shRNA4Xcells (3× 106) were treatedwith tetracycline at the
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dUTPase Silencing by RNAi in HeLa Cells 387
concentration of 1µg/ml for 72 hours, then lyzed in buffer (50mMTris-HCl
pH 7.4, 140 mMNaCl, 1 mMDTT, 1 mM protease inhibitor-cocktail) on ice.
The protein extract concentration was determined by Bio-Rad Protein Assay
reagent (Bio-Rad Laboratories Ltd., UK). The procedure was conducted as
described previously.[36] Briefly, the malachite green reagent was prepared
freshly and containedmalachite green, polyvinyl alcohol, ammoniummolyb-
date, and distilled water (in a ratio of 2:1:1:2). The procedure was carried out
onto 96 well-plate at room temperature. The reaction mixture (50 µl) con-
tained 0.5µg/µl protein extract, assay buffer (1mMHEPES pH 7.5, 150mM
KCl, 1 mMMgCl2) and 0.02 unit/µl pyrophosphatase enzyme. After starting
the reaction with adding 40 µM dUTP, samples were taken and mixed with
malachite green reagent in a ratio of 1:4. After five minutes incubation the
optical density was determined using a ND-1000 UV-vis spectrophotometer.
Quantitative values for dUTPase activity were derived from a standard curve.
Each experiment was performed in duplicate and standard deviation values
were calculated from two independent measurements at different times.
Recombinant Protein Expression and Reaction Conditions
for dUTPase Enzyme Activity and Ligand Binding Studies
The His-tagged nuclear isoform of the human dUTPase Phe158Trp mu-
tant construct (hDUTW158) was expressed and purified as described previ-
ously.[28] This mutation allows direct characterization of dUTP hydrolysis
kinetics and determination of dissociation constant of dUTPase-nucleotide
complexes as described elsewhere.[28,34,37] The protein concentration was
measured using the BioRad Protein Assay reagent and by UV absorbance
(λ280 = 15930 M−1cm−1 for hDUTW158) and is given in monomers. All mea-
surements involving hDUTW158 were carried out in 20 mM HEPES pH 7.5
buffer, also containing 100 mM NaCl, 5 mM MgCl2,[38,39] and 2 mM DTT
(unless otherwise stated), at 20◦C.
dUTPase Activity Measurement by Stopped-Flow Analysis
Measurements were done using a SX-20 (Applied Photophysics, UK)
stopped-flow apparatus, as described before.[28] Tryptophan fluorescence
was excited at 295 nm and emission was selected with a 320 nm long-pass
filter. Time courses were analyzed using the curve fitting software provided
with the stopped-flow apparatus or by Origin 7.5.
Determination of Dissociation Constant of the Complex Formed
Between dUTPase and FdUMP
Fluorescence intensity titrations were recorded on a Jobin Yvon Spex
Fluoromax-3 spectrofluorometer with excitation at 295 nm (slit 1 nm), emis-
sion at 353 nm (slit 5 nm) at 2.7 µM protein concentration. Fluorescence
intensity data were plotted against the FdUMP concentration and fitted with
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388 G. Mere´nyi et al.
a quadratic function (Equation (1)) to extract the dissociation constant.
y = s + A ∗
(
(c + x + K)−
√
(c + x + K)2 − 4 ∗ c ∗ x
)
/2 ∗ c (1)
where s = y at c = 0, A = amplitude, c = concentration of the constant
component, and K = dissociation constant.
Statistical Analysis
Data were analyzed using OriginPro7.5 software (www.originlab.com).
Each experiment was repeated at least two or three times. Data represent
the mean ±SD (standard deviation) of two or three determinations. A two-
tailed student’s t test was used for estimations of significance, with P < 0.05
considered to be significant.
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